Real-world outcomes of infections following tisagenlecleucel in patients with B-cell ALL: a CIBMTR analysis

Hemalatha G. Rangarajan, Prakash Satwani, Megan M. Herr, Min Chen, Michael J. Martens, Kitsada Wudhikarn, Samuel John, Vanessa A. Fabrizio, Emily M. Hsieh, Amar H. Kelkar, Erin Doherty, David I. Marks, Olle Ringden, Brian Friend, Matthew S. Kelly, Nosha Farhadfar, Tim Prestidge, Nasheed M. Hossain, Hongtao Liu, Shahrukh Hashmi, Dipenkumar Modi, Lena E. Winestone, Zeinab El Boghdadly, Hemant S. Murthy, Miguel-Angel Perales, Roy F. Chemaly, Christopher E. Dandoy, Joshua A. Hill, Anna Huppler, Marcie Riches, Jeffery J. Auletta

Open source

DOI: 10.1182/bloodadvances.2025016149
Published: 2025-10-30
Container: Blood Advances
Publisher: American Society of Hematology
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1182/bloodadvances.2025016149,
  title = {Real-world outcomes of infections following tisagenlecleucel in patients with B-cell ALL: a CIBMTR analysis},
  author = {Hemalatha G. Rangarajan and Prakash Satwani and Megan M. Herr and Min Chen and Michael J. Martens and Kitsada Wudhikarn and Samuel John and Vanessa A. Fabrizio and Emily M. Hsieh and Amar H. Kelkar and Erin Doherty and David I. Marks and Olle Ringden and Brian Friend and Matthew S. Kelly and Nosha Farhadfar and Tim Prestidge and Nasheed M. Hossain and Hongtao Liu and Shahrukh Hashmi and Dipenkumar Modi and Lena E. Winestone and Zeinab El Boghdadly and Hemant S. Murthy and Miguel-Angel Perales and Roy F. Chemaly and Christopher E. Dandoy and Joshua A. Hill and Anna Huppler and Marcie Riches and Jeffery J. Auletta},
  year = {2025},
  journal = {Blood Advances},
  doi = {10.1182/bloodadvances.2025016149},
  url = {https://doi.org/10.1182/bloodadvances.2025016149}
}

RIS

TY  - JOUR
TI  - Real-world outcomes of infections following tisagenlecleucel in patients with B-cell ALL: a CIBMTR analysis
AU  - Hemalatha G. Rangarajan
AU  - Prakash Satwani
AU  - Megan M. Herr
AU  - Min Chen
AU  - Michael J. Martens
AU  - Kitsada Wudhikarn
AU  - Samuel John
AU  - Vanessa A. Fabrizio
AU  - Emily M. Hsieh
AU  - Amar H. Kelkar
AU  - Erin Doherty
AU  - David I. Marks
AU  - Olle Ringden
AU  - Brian Friend
AU  - Matthew S. Kelly
AU  - Nosha Farhadfar
AU  - Tim Prestidge
AU  - Nasheed M. Hossain
AU  - Hongtao Liu
AU  - Shahrukh Hashmi
AU  - Dipenkumar Modi
AU  - Lena E. Winestone
AU  - Zeinab El Boghdadly
AU  - Hemant S. Murthy
AU  - Miguel-Angel Perales
AU  - Roy F. Chemaly
AU  - Christopher E. Dandoy
AU  - Joshua A. Hill
AU  - Anna Huppler
AU  - Marcie Riches
AU  - Jeffery J. Auletta
PY  - 2025
JO  - Blood Advances
DO  - 10.1182/bloodadvances.2025016149
UR  - https://doi.org/10.1182/bloodadvances.2025016149
ER  -

APA

Rangarajan, H. G., Satwani, P., Herr, M. M., Chen, M., Martens, M. J., Wudhikarn, K., John, S., Fabrizio, V. A., Hsieh, E. M., Kelkar, A. H., Doherty, E., Marks, D. I., Ringden, O., Friend, B., Kelly, M. S., Farhadfar, N., Prestidge, T., Hossain, N. M., Liu, H., Hashmi, S., Modi, D., Winestone, L. E., Boghdadly, Z. E., Murthy, H. S., Perales, M., Chemaly, R. F., Dandoy, C. E., Hill, J. A., Huppler, A., Riches, M., & Auletta, J. J. (2025). Real-world outcomes of infections following tisagenlecleucel in patients with B-cell ALL: a CIBMTR analysis. Blood Advances. https://doi.org/10.1182/bloodadvances.2025016149

Source records

crossref · retrieved 2026-09-26T20:25:10.433Z